Development of explicit definitions of potentially inappropriate prescriptions for antidiabetic drugs in patients with type 2 diabetes: A multidisciplinary qualitative study

The results of our qualitative study show that it is possible to develop a specific list of explicit definitions of potentially inappropriate prescriptions of antidiabetic drugs in patients with type 2 diabetes mellitus by gathering the opinions of healthcare professionals caring for these patients. This list of 38 explicit definitions necessitates additional confirmation by expert consensus before use in clinical practice.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2024-09-27
DOI
https://doi.org/10.1371/journal.pone.0309290
Citations
1
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.34

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of explicit definitions of potentially inappropriate prescriptions for antidiabetic drugs in patients with type 2 diabetes: A multidisciplinary qualitative study

Jean‐Baptiste Beuscart, Paul Quindroit, Sophie Gautier, Jan Baran et al.
1 citations
PLoS ONE
Pharmaceutical Practices and Patient Outcomes
0.34
article

Development of explicit definitions of potentially inappropriate prescriptions for antidiabetic drugs in patients with type 2 diabetes: A multidisciplinary qualitative study

Jean‐Baptiste Beuscart, Paul Quindroit, Sophie Gautier, Jan Baran, Erwin Gerard, Stéphanie Genay, Madleen Lemaître, Bertrand Décaudin, A. Vambergue, Matthieu Calafiore
article en
1 citations

Abstract

The results of our qualitative study show that it is possible to develop a specific list of explicit definitions of potentially inappropriate prescriptions of antidiabetic drugs in patients with type 2 diabetes mellitus by gathering the opinions of healthcare professionals caring for these patients. This list of 38 explicit definitions necessitates additional confirmation by expert consensus before use in clinical practice.

PLoS ONEVol. 19(9)
Université de Lille (FR), Centre Hospitalier Universitaire de Lille (FR), Lille’s Cardiology Hospital (FR), Centre de Recherche Jean Pierre Aubert (FR), European Genomic Institute for Diabetes (FR), Evaluation des technologies de santé et des pratiques médicales (FR)
European Commission, Agence Nationale de la Recherche, Conseil Régional Hauts-de-France, CHIST-ERA
Good health and well-being
Openalex Percentile: Top 39%
Pharmaceutical Practices and Patient Outcomes
0.34
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.